APO Research
Talk to an analyst

APO RESEARCH · REPORT

FABP1 Antibody

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global FABP1 Antibody Industry Growth and Trends Forecast to 2032

19 December 2025117 pages

Choose your research edition.

Industry ResearchFABP1 Antibody Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal FABP1 Antibody Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal FABP1 Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal FABP1 Antibody Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal FABP1 Antibody Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global FABP1 Antibody market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for FABP1 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for FABP1 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for FABP1 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of FABP1 Antibody include Thermo Fisher Scientific, Merck, United States Biological, Santa Cruz Biotechnology, Proteintech, ProSci, NSJ Bioreagents, G Biosciences and FineTest, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global FABP1 Antibody market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The FABP1 Antibody market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global FABP1 Antibody market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to FABP1 Antibody.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global FABP1 Antibody market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

FABP1 Antibody Market by Company

Thermo Fisher Scientific

Merck

United States Biological

Santa Cruz Biotechnology

Proteintech

ProSci

NSJ Bioreagents

G Biosciences

FineTest

CUSABIO

Cell Signaling Technology

Boster Biological Technology

BioLegend

Aviva Systems Biology

Affinity Biosciences

Abnova

Abcam

FABP1 Antibody Segment by Type

Polyclonal

Monoclonal

FABP1 Antibody Segment by Application

Western Blot

Immunofluorescence

Immunohistochemistry

Others

FABP1 Antibody Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global FABP1 Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of FABP1 Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of FABP1 Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of FABP1 Antibody manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of FABP1 Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Polyclonal Table 2. Major Company of Monoclonal Table 3. Global FABP1 Antibody Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global FABP1 Antibody Sales by Type (2021-2026) & (Kg) Table 5. Global FABP1 Antibody Sales Market Share in Volume by Type (2021-2026) Table 6. Global FABP1 Antibody Sales by Type (2021-2026) & (US$ Million) Table 7. Global FABP1 Antibody Sales Market Share in Value by Type (2021-2026) Table 8. Global FABP1 Antibody Price by Type (2021-2026) & (US$/Kg) Table 9. Global FABP1 Antibody Sales by Type (2027-2032) & (Kg) Table 10. Global FABP1 Antibody Sales Market Share in Volume by Type (2027-2032) Table 11. Global FABP1 Antibody Sales by Type (2027-2032) & (US$ Million) Table 12. Global FABP1 Antibody Sales Market Share in Value by Type (2027-2032) Table 13. Global FABP1 Antibody Price by Type (2027-2032) & (US$/Kg) Table 14. North America FABP1 Antibody Sales by Type (2021-2026) & (Kg) Table 15. North America FABP1 Antibody Sales by Type (2021-2026) & (US$ Million) Table 16. Europe FABP1 Antibody Sales by Type (2021-2026) & (Kg) Table 17. Europe FABP1 Antibody Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific FABP1 Antibody Sales by Type (2021-2026) & (Kg) Table 19. Asia-Pacific FABP1 Antibody Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America FABP1 Antibody Sales by Type (2021-2026) & (Kg) Table 21. Latin America FABP1 Antibody Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa FABP1 Antibody Sales by Type (2021-2026) & (Kg) Table 23. Middle East and Africa FABP1 Antibody Sales by Type (2021-2026) & (US$ Million) Table 24. FABP1 Antibody Industry Trends Table 25. FABP1 Antibody Industry Drivers Table 26. FABP1 Antibody Industry Opportunities and Challenges Table 27. FABP1 Antibody Industry Restraints Table 28. Global FABP1 Antibody Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global FABP1 Antibody Revenue Market Share by Company (2021-2026) Table 30. Global FABP1 Antibody Sales by Company (2021-2026) & (Kg) Table 31. Global FABP1 Antibody Sales Share by Company (2021-2026) Table 32. Global FABP1 Antibody Market Price by Company (2021-2026) & (US$/Kg) Table 33. Global FABP1 Antibody Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global FABP1 Antibody Major Company Production Sites and Headquarters Table 35. Global FABP1 Antibody Company, Product Type & Application Table 36. Global FABP1 Antibody Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global FABP1 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global FABP1 Antibody Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global FABP1 Antibody Sales by Region (2021-2026) & (Kg) Table 41. Global FABP1 Antibody Sales Market Share in Volume by Region (2021-2026) Table 42. Global FABP1 Antibody Sales by Region (2021-2026) & (US$ Million) Table 43. Global FABP1 Antibody Sales Market Share in Value by Region (2021-2026) Table 44. Global FABP1 Antibody Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 45. Global FABP1 Antibody Sales by Region (2027-2032) & (Kg) Table 46. Global FABP1 Antibody Sales Market Share in Volume by Region (2027-2032) Table 47. Global FABP1 Antibody Sales by Region (2027-2032) & (US$ Million) Table 48. Global FABP1 Antibody Sales Market Share in Value by Region (2027-2032) Table 49. Global FABP1 Antibody Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 50. Global FABP1 Antibody Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global FABP1 Antibody Sales by Application (2021-2026) & (Kg) Table 52. Global FABP1 Antibody Sales Market Share in Volume by Application (2021-2026) Table 53. Global FABP1 Antibody Sales by Application (2021-2026) & (US$ Million) Table 54. Global FABP1 Antibody Sales Market Share in Value by Application (2021-2026) Table 55. Global FABP1 Antibody Price by Application (2021-2026) & (US$/Kg) Table 56. Global FABP1 Antibody Sales by Application (2027-2032) & (Kg) Table 57. Global FABP1 Antibody Sales Market Share in Volume by Application (2027-2032) Table 58. Global FABP1 Antibody Sales by Application (2027-2032) & (US$ Million) Table 59. Global FABP1 Antibody Sales Market Share in Value by Application (2027-2032) Table 60. Global FABP1 Antibody Price by Application (2027-2032) & (US$/Kg) Table 61. North America FABP1 Antibody Sales by Application (2021-2026) & (Kg) Table 62. North America FABP1 Antibody Sales by Application (2021-2026) & (US$ Million) Table 63. Europe FABP1 Antibody Sales by Application (2021-2026) & (Kg) Table 64. Europe FABP1 Antibody Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific FABP1 Antibody Sales by Application (2021-2026) & (Kg) Table 66. Asia-Pacific FABP1 Antibody Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America FABP1 Antibody Sales by Application (2021-2026) & (Kg) Table 68. Latin America FABP1 Antibody Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa FABP1 Antibody Sales by Application (2021-2026) & (Kg) Table 70. Middle East and Africa FABP1 Antibody Sales by Application (2021-2026) & (US$ Million) Table 71. Thermo Fisher Scientific Company Information Table 72. Thermo Fisher Scientific Business Overview Table 73. Thermo Fisher Scientific FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 74. Thermo Fisher Scientific FABP1 Antibody Product Portfolio Table 75. Thermo Fisher Scientific Recent Development Table 76. Merck Company Information Table 77. Merck Business Overview Table 78. Merck FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 79. Merck FABP1 Antibody Product Portfolio Table 80. Merck Recent Development Table 81. United States Biological Company Information Table 82. United States Biological Business Overview Table 83. United States Biological FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 84. United States Biological FABP1 Antibody Product Portfolio Table 85. United States Biological Recent Development Table 86. Santa Cruz Biotechnology Company Information Table 87. Santa Cruz Biotechnology Business Overview Table 88. Santa Cruz Biotechnology FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 89. Santa Cruz Biotechnology FABP1 Antibody Product Portfolio Table 90. Santa Cruz Biotechnology Recent Development Table 91. Proteintech Company Information Table 92. Proteintech Business Overview Table 93. Proteintech FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 94. Proteintech FABP1 Antibody Product Portfolio Table 95. Proteintech Recent Development Table 96. ProSci Company Information Table 97. ProSci Business Overview Table 98. ProSci FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 99. ProSci FABP1 Antibody Product Portfolio Table 100. ProSci Recent Development Table 101. NSJ Bioreagents Company Information Table 102. NSJ Bioreagents Business Overview Table 103. NSJ Bioreagents FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 104. NSJ Bioreagents FABP1 Antibody Product Portfolio Table 105. NSJ Bioreagents Recent Development Table 106. G Biosciences Company Information Table 107. G Biosciences Business Overview Table 108. G Biosciences FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 109. G Biosciences FABP1 Antibody Product Portfolio Table 110. G Biosciences Recent Development Table 111. FineTest Company Information Table 112. FineTest Business Overview Table 113. FineTest FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 114. FineTest FABP1 Antibody Product Portfolio Table 115. FineTest Recent Development Table 116. CUSABIO Company Information Table 117. CUSABIO Business Overview Table 118. CUSABIO FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 119. CUSABIO FABP1 Antibody Product Portfolio Table 120. CUSABIO Recent Development Table 121. Cell Signaling Technology Company Information Table 122. Cell Signaling Technology Business Overview Table 123. Cell Signaling Technology FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 124. Cell Signaling Technology FABP1 Antibody Product Portfolio Table 125. Cell Signaling Technology Recent Development Table 126. Boster Biological Technology Company Information Table 127. Boster Biological Technology Business Overview Table 128. Boster Biological Technology FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 129. Boster Biological Technology FABP1 Antibody Product Portfolio Table 130. Boster Biological Technology Recent Development Table 131. BioLegend Company Information Table 132. BioLegend Business Overview Table 133. BioLegend FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 134. BioLegend FABP1 Antibody Product Portfolio Table 135. BioLegend Recent Development Table 136. Aviva Systems Biology Company Information Table 137. Aviva Systems Biology Business Overview Table 138. Aviva Systems Biology FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 139. Aviva Systems Biology FABP1 Antibody Product Portfolio Table 140. Aviva Systems Biology Recent Development Table 141. Affinity Biosciences Company Information Table 142. Affinity Biosciences Business Overview Table 143. Affinity Biosciences FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 144. Affinity Biosciences FABP1 Antibody Product Portfolio Table 145. Affinity Biosciences Recent Development Table 146. Abnova Company Information Table 147. Abnova Business Overview Table 148. Abnova FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 149. Abnova FABP1 Antibody Product Portfolio Table 150. Abnova Recent Development Table 151. Abcam Company Information Table 152. Abcam Business Overview Table 153. Abcam FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 154. Abcam FABP1 Antibody Product Portfolio Table 155. Abcam Recent Development Table 156. North America FABP1 Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 157. North America FABP1 Antibody Sales by Country (2021-2026) & (Kg) Table 158. North America FABP1 Antibody Sales Market Share by Country (2021-2026) Table 159. North America FABP1 Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 160. North America FABP1 Antibody Sales Market Share Forecast by Country (2027-2032) Table 161. North America FABP1 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. North America FABP1 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 163. North America FABP1 Antibody Market Share by Country (2021-2026) Table 164. North America FABP1 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. North America FABP1 Antibody Market Share Forecast by Country (2027-2032) Table 166. Europe FABP1 Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 167. Europe FABP1 Antibody Sales by Country (2021-2026) & (Kg) Table 168. Europe FABP1 Antibody Sales Market Share by Country (2021-2026) Table 169. Europe FABP1 Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 170. Europe FABP1 Antibody Sales Market Share Forecast by Country (2027-2032) Table 171. Europe FABP1 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Europe FABP1 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 173. Europe FABP1 Antibody Market Share by Country (2021-2026) Table 174. Europe FABP1 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Europe FABP1 Antibody Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific FABP1 Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific FABP1 Antibody Sales by Country (2021-2026) & (Kg) Table 178. Asia-Pacific FABP1 Antibody Sales Market Share by Country (2021-2026) Table 179. Asia-Pacific FABP1 Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 180. Asia-Pacific FABP1 Antibody Sales Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific FABP1 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific FABP1 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 183. Asia-Pacific FABP1 Antibody Market Share by Country (2021-2026) Table 184. Asia-Pacific FABP1 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Asia-Pacific FABP1 Antibody Market Share Forecast by Country (2027-2032) Table 186. Latin America FABP1 Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 187. Latin America FABP1 Antibody Sales by Country (2021-2026) & (Kg) Table 188. Latin America FABP1 Antibody Sales Market Share by Country (2021-2026) Table 189. Latin America FABP1 Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 190. Latin America FABP1 Antibody Sales Market Share Forecast by Country (2027-2032) Table 191. Latin America FABP1 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Latin America FABP1 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 193. Latin America FABP1 Antibody Market Share by Country (2021-2026) Table 194. Latin America FABP1 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Latin America FABP1 Antibody Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa FABP1 Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa FABP1 Antibody Sales by Country (2021-2026) & (Kg) Table 198. Middle East and Africa FABP1 Antibody Sales Market Share by Country (2021-2026) Table 199. Middle East and Africa FABP1 Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 200. Middle East and Africa FABP1 Antibody Sales Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa FABP1 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa FABP1 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 203. Middle East and Africa FABP1 Antibody Market Share by Country (2021-2026) Table 204. Middle East and Africa FABP1 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Middle East and Africa FABP1 Antibody Market Share Forecast by Country (2027-2032) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. FABP1 Antibody Distributors List Table 209. FABP1 Antibody Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. FABP1 Antibody Image Figure 2. Global FABP1 Antibody Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global FABP1 Antibody Market Size (2021-2032) & (US$ Million) Figure 4. Global FABP1 Antibody Sales (2021-2032) & (Kg) Figure 5. Polyclonal Image Figure 6. Global Polyclonal Sales YoY Growth (2021-2032) & (Kg) Figure 7. Monoclonal Image Figure 8. Global Monoclonal Sales YoY Growth (2021-2032) & (Kg) Figure 9. Global FABP1 Antibody Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global FABP1 Antibody Market Share by Type 2025 VS 2032 Figure 11. North America FABP1 Antibody Sales Market Share in Volume by Type in 2025 Figure 12. North America FABP1 Antibody Sales Market Share in Value by Type in 2025 Figure 13. Europe FABP1 Antibody Sales Market Share in Volume by Type in 2025 Figure 14. Europe FABP1 Antibody Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific FABP1 Antibody Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific FABP1 Antibody Sales Market Share in Value by Type in 2025 Figure 17. Latin America FABP1 Antibody Sales Market Share in Volume by Type in 2025 Figure 18. Latin America FABP1 Antibody Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa FABP1 Antibody Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa FABP1 Antibody Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 FABP1 Antibody Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Western Blot Image Figure 24. Global Western Blot Sales YoY Growth (2021-2032) & (Kg) Figure 25. Immunofluorescence Image Figure 26. Global Immunofluorescence Sales YoY Growth (2021-2032) & (Kg) Figure 27. Immunohistochemistry Image Figure 28. Global Immunohistochemistry Sales YoY Growth (2021-2032) & (Kg) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (Kg) Figure 31. Global FABP1 Antibody Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global FABP1 Antibody Market Share by Application 2025 VS 2032 Figure 33. North America FABP1 Antibody Sales Market Share in Volume by Application in 2025 Figure 34. North America FABP1 Antibody Sales Market Share in Value by Application in 2025 Figure 35. Europe FABP1 Antibody Sales Market Share in Volume by Application in 2025 Figure 36. Europe FABP1 Antibody Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific FABP1 Antibody Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific FABP1 Antibody Sales Market Share in Value by Application in 2025 Figure 39. Latin America FABP1 Antibody Sales Market Share in Volume by Application in 2025 Figure 40. Latin America FABP1 Antibody Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa FABP1 Antibody Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa FABP1 Antibody Sales Market Share in Value by Application in 2025 Figure 43. North America FABP1 Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 44. North America FABP1 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America FABP1 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America FABP1 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe FABP1 Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 48. Europe FABP1 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe FABP1 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe FABP1 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific FABP1 Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 52. Asia-Pacific FABP1 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific FABP1 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific FABP1 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America FABP1 Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 56. Latin America FABP1 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America FABP1 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America FABP1 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa FABP1 Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 60. Middle East and Africa FABP1 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa FABP1 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa FABP1 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. FABP1 Antibody Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. FABP1 Antibody Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Polyclonal
  • Monoclonal
Applications
  • Western Blot
  • Immunofluorescence
  • Immunohistochemistry
  • Others
Companies covered
  • Thermo Fisher Scientific
  • Merck
  • United States Biological
  • Santa Cruz Biotechnology
  • Proteintech
  • ProSci
  • NSJ Bioreagents
  • G Biosciences
  • FineTest
  • CUSABIO
  • Cell Signaling Technology
  • Boster Biological Technology
  • BioLegend
  • Aviva Systems Biology
  • Affinity Biosciences
  • Abnova
  • Abcam

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global FABP1 Antibody Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global FABP1 Antibody Sales Estimates and Forecasts (2021-2032)
  5. 1.3 FABP1 Antibody Market by Type
  6. 1.3.1 Polyclonal
  7. 1.3.2 Monoclonal
  8. 1.4 Global FABP1 Antibody Market Size by Type
  9. 1.4.1 Global FABP1 Antibody Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global FABP1 Antibody Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global FABP1 Antibody Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America FABP1 Antibody Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe FABP1 Antibody Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific FABP1 Antibody Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America FABP1 Antibody Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa FABP1 Antibody Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 FABP1 Antibody Industry Trends
  2. 2.2 FABP1 Antibody Industry Drivers
  3. 2.3 FABP1 Antibody Industry Opportunities and Challenges
  4. 2.4 FABP1 Antibody Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by FABP1 Antibody Revenue (2021-2026)
  2. 3.2 Global Top Players by FABP1 Antibody Sales (2021-2026)
  3. 3.3 Global Top Players by FABP1 Antibody Price (2021-2026)
  4. 3.4 Global FABP1 Antibody Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global FABP1 Antibody Major Company Production Sites & Headquarters
  6. 3.6 Global FABP1 Antibody Company, Product Type & Application
  7. 3.7 Global FABP1 Antibody Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global FABP1 Antibody Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 FABP1 Antibody Players Market Share by Revenue in 2025
  11. 3.8.3 2025 FABP1 Antibody Tier 1, Tier 2, and Tier 3
4 FABP1 Antibody Regional Status and Outlook
  1. 4.1 Global FABP1 Antibody Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global FABP1 Antibody Historic Market Size by Region
  3. 4.2.1 Global FABP1 Antibody Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global FABP1 Antibody Sales in Value by Region (2021-2026)
  5. 4.2.3 Global FABP1 Antibody Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global FABP1 Antibody Forecasted Market Size by Region
  7. 4.3.1 Global FABP1 Antibody Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global FABP1 Antibody Sales in Value by Region (2027-2032)
  9. 4.3.3 Global FABP1 Antibody Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 FABP1 Antibody by Application
  1. 5.1 FABP1 Antibody Market by Application
  2. 5.1.1 Western Blot
  3. 5.1.2 Immunofluorescence
  4. 5.1.3 Immunohistochemistry
  5. 5.1.4 Others
  6. 5.2 Global FABP1 Antibody Market Size by Application
  7. 5.2.1 Global FABP1 Antibody Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global FABP1 Antibody Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global FABP1 Antibody Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America FABP1 Antibody Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe FABP1 Antibody Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific FABP1 Antibody Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America FABP1 Antibody Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa FABP1 Antibody Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Thermo Fisher Scientific
  2. 6.1.1 Thermo Fisher Scientific Company Information
  3. 6.1.2 Thermo Fisher Scientific Business Overview
  4. 6.1.3 Thermo Fisher Scientific FABP1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Thermo Fisher Scientific FABP1 Antibody Product Portfolio
  6. 6.1.5 Thermo Fisher Scientific Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck FABP1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck FABP1 Antibody Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 United States Biological
  14. 6.3.1 United States Biological Company Information
  15. 6.3.2 United States Biological Business Overview
  16. 6.3.3 United States Biological FABP1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 United States Biological FABP1 Antibody Product Portfolio
  18. 6.3.5 United States Biological Recent Developments
  19. 6.4 Santa Cruz Biotechnology
  20. 6.4.1 Santa Cruz Biotechnology Company Information
  21. 6.4.2 Santa Cruz Biotechnology Business Overview
  22. 6.4.3 Santa Cruz Biotechnology FABP1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Santa Cruz Biotechnology FABP1 Antibody Product Portfolio
  24. 6.4.5 Santa Cruz Biotechnology Recent Developments
  25. 6.5 Proteintech
  26. 6.5.1 Proteintech Company Information
  27. 6.5.2 Proteintech Business Overview
  28. 6.5.3 Proteintech FABP1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Proteintech FABP1 Antibody Product Portfolio
  30. 6.5.5 Proteintech Recent Developments
  31. 6.6 ProSci
  32. 6.6.1 ProSci Company Information
  33. 6.6.2 ProSci Business Overview
  34. 6.6.3 ProSci FABP1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 ProSci FABP1 Antibody Product Portfolio
  36. 6.6.5 ProSci Recent Developments
  37. 6.7 NSJ Bioreagents
  38. 6.7.1 NSJ Bioreagents Company Information
  39. 6.7.2 NSJ Bioreagents Business Overview
  40. 6.7.3 NSJ Bioreagents FABP1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 NSJ Bioreagents FABP1 Antibody Product Portfolio
  42. 6.7.5 NSJ Bioreagents Recent Developments
  43. 6.8 G Biosciences
  44. 6.8.1 G Biosciences Company Information
  45. 6.8.2 G Biosciences Business Overview
  46. 6.8.3 G Biosciences FABP1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 G Biosciences FABP1 Antibody Product Portfolio
  48. 6.8.5 G Biosciences Recent Developments
  49. 6.9 FineTest
  50. 6.9.1 FineTest Company Information
  51. 6.9.2 FineTest Business Overview
  52. 6.9.3 FineTest FABP1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 FineTest FABP1 Antibody Product Portfolio
  54. 6.9.5 FineTest Recent Developments
  55. 6.10 CUSABIO
  56. 6.10.1 CUSABIO Company Information
  57. 6.10.2 CUSABIO Business Overview
  58. 6.10.3 CUSABIO FABP1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 CUSABIO FABP1 Antibody Product Portfolio
  60. 6.10.5 CUSABIO Recent Developments
  61. 6.11 Cell Signaling Technology
  62. 6.11.1 Cell Signaling Technology Company Information
  63. 6.11.2 Cell Signaling Technology Business Overview
  64. 6.11.3 Cell Signaling Technology FABP1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Cell Signaling Technology FABP1 Antibody Product Portfolio
  66. 6.11.5 Cell Signaling Technology Recent Developments
  67. 6.12 Boster Biological Technology
  68. 6.12.1 Boster Biological Technology Company Information
  69. 6.12.2 Boster Biological Technology Business Overview
  70. 6.12.3 Boster Biological Technology FABP1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Boster Biological Technology FABP1 Antibody Product Portfolio
  72. 6.12.5 Boster Biological Technology Recent Developments
  73. 6.13 BioLegend
  74. 6.13.1 BioLegend Company Information
  75. 6.13.2 BioLegend Business Overview
  76. 6.13.3 BioLegend FABP1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 BioLegend FABP1 Antibody Product Portfolio
  78. 6.13.5 BioLegend Recent Developments
  79. 6.14 Aviva Systems Biology
  80. 6.14.1 Aviva Systems Biology Company Information
  81. 6.14.2 Aviva Systems Biology Business Overview
  82. 6.14.3 Aviva Systems Biology FABP1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Aviva Systems Biology FABP1 Antibody Product Portfolio
  84. 6.14.5 Aviva Systems Biology Recent Developments
  85. 6.15 Affinity Biosciences
  86. 6.15.1 Affinity Biosciences Company Information
  87. 6.15.2 Affinity Biosciences Business Overview
  88. 6.15.3 Affinity Biosciences FABP1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Affinity Biosciences FABP1 Antibody Product Portfolio
  90. 6.15.5 Affinity Biosciences Recent Developments
  91. 6.16 Abnova
  92. 6.16.1 Abnova Company Information
  93. 6.16.2 Abnova Business Overview
  94. 6.16.3 Abnova FABP1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Abnova FABP1 Antibody Product Portfolio
  96. 6.16.5 Abnova Recent Developments
  97. 6.17 Abcam
  98. 6.17.1 Abcam Company Information
  99. 6.17.2 Abcam Business Overview
  100. 6.17.3 Abcam FABP1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Abcam FABP1 Antibody Product Portfolio
  102. 6.17.5 Abcam Recent Developments
7 North America by Country
  1. 7.1 North America FABP1 Antibody Sales by Country
  2. 7.1.1 North America FABP1 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America FABP1 Antibody Sales by Country (2021-2026)
  4. 7.1.3 North America FABP1 Antibody Sales Forecast by Country (2027-2032)
  5. 7.2 North America FABP1 Antibody Market Size by Country
  6. 7.2.1 North America FABP1 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America FABP1 Antibody Market Size by Country (2021-2026)
  8. 7.2.3 North America FABP1 Antibody Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe FABP1 Antibody Sales by Country
  2. 8.1.1 Europe FABP1 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe FABP1 Antibody Sales by Country (2021-2026)
  4. 8.1.3 Europe FABP1 Antibody Sales Forecast by Country (2027-2032)
  5. 8.2 Europe FABP1 Antibody Market Size by Country
  6. 8.2.1 Europe FABP1 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe FABP1 Antibody Market Size by Country (2021-2026)
  8. 8.2.3 Europe FABP1 Antibody Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific FABP1 Antibody Sales by Country
  2. 9.1.1 Asia-Pacific FABP1 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific FABP1 Antibody Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific FABP1 Antibody Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific FABP1 Antibody Market Size by Country
  6. 9.2.1 Asia-Pacific FABP1 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific FABP1 Antibody Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific FABP1 Antibody Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America FABP1 Antibody Sales by Country
  2. 10.1.1 South America FABP1 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America FABP1 Antibody Sales by Country (2021-2026)
  4. 10.1.3 South America FABP1 Antibody Sales Forecast by Country (2027-2032)
  5. 10.2 South America FABP1 Antibody Market Size by Country
  6. 10.2.1 South America FABP1 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America FABP1 Antibody Market Size by Country (2021-2026)
  8. 10.2.3 South America FABP1 Antibody Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa FABP1 Antibody Sales by Country
  2. 11.1.1 Middle East and Africa FABP1 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa FABP1 Antibody Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa FABP1 Antibody Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa FABP1 Antibody Market Size by Country
  6. 11.2.1 Middle East and Africa FABP1 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa FABP1 Antibody Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa FABP1 Antibody Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 FABP1 Antibody Value Chain Analysis
  2. 12.1.1 FABP1 Antibody Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 FABP1 Antibody Production Mode & Process
  7. 12.2 FABP1 Antibody Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 FABP1 Antibody Distributors
  10. 12.2.3 FABP1 Antibody Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst